Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Longeveron Inc.Longeveron Reports 415% Revenue Growth, Net Loss Reduction in Q3 2024
SAGA COMMUNICATIONS INCSAGA Communications Reports Decline in Revenue and Profitability for Q3 and Nine Months Ended September 30, 2024
FIRST COMMONWEALTH FINANCIAL CORP /PA/First Commonwealth Financial Corporation Reports Mixed Q3 and 9M Results, with Asset Growth and Increased Retained Earnings
PREMIER FINANCIAL CORPPremier Financial Corp. Reports Decline in Net Income and Net Interest Income in Q3 2024
Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals Reports Financial Results, Raises Funds Amid Ongoing Clinical Development of Ibezapolstat
Lite Strategy, Inc.MEI Pharma Reports Significant Financial Challenges, Net Loss, and Halted Clinical Trials in Q3 2024
FIDELITY D & D BANCORP INCFidelity D & D Bancorp Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024
Beacon Financial CorpBerkshire Hills Bancorp Reports 3Q 2024 Financial Results, Net Income Up 92% Year-Over-Year
IGC Pharma, Inc.IGC Pharma Reports 42% Revenue Growth, Improved Profitability, and Advancements in Clinical Pipeline
TRIUMPH GROUP INCTriumph Group Reports Improved Revenue and Profitability in Q2 2024
OPAL Fuels Inc.OPAL Fuels Reports 18.2% Revenue Growth, Net Income Increase in Q3 2024
CoinShares Bitcoin ETFCoinShares Valkyrie Bitcoin Fund Reports $569.8M in Assets, 2.39% Total Return at NAV
First Guaranty Bancshares, Inc.First Guaranty Bancshares Reports 10.4% Asset Growth, 44.5% Net Income Increase in Q3 2024
Corvus Pharmaceuticals, Inc.Corvus Pharmaceuticals Reports Significant Financial Changes, Net Loss Increases to $40.2 Million in Q3 2024
FATE THERAPEUTICS INCFate Therapeutics Reports Q3 2024 Financial Results, Collaboration Revenue Decreases Due to Janssen Biotech Termination
TechTarget IncTechTarget Reports Mixed Q3 Results, Net Loss, and Increased Cash Reserves Ahead of Informa Merger
Serina Therapeutics, Inc.Serina Therapeutics Reports Mixed Financial Results, Raises Concerns Over Going Concern
PROKIDNEY CORP.ProKidney Corp. Reports Financial Results, Cash and Cash Equivalents Increase to $108.1 Million
SANGAMO THERAPEUTICS, INCSangamo Therapeutics Reports Mixed Financial Results, Seeks Additional Capital Amid Restructuring Efforts
UNITED STATES ANTIMONY CORPUnited States Antimony Corporation Reports Revenue Growth, Net Loss in Q3 2024
KOPIN CORPKopin Corporation Reports Revenue Growth, Net Loss, and Increased Liabilities in Latest Quarter
Sanara MedTech Inc.Sanara MedTech Reports 35% Revenue Growth, Increased Debt, and Net Loss in Latest Quarter
PERDOCEO EDUCATION CorpPerdoceo Education Reports Decline in Revenue, Increase in Operating Income for Q3 2024
HarborOne Bancorp, Inc.HarborOne Bancorp Reports Decline in Profitability Amid Rising Credit Loss Provisions
AMERICAN PUBLIC EDUCATION INCAmerican Public Education Reports Improved Revenue and Profitability in Q3 2024